Enteric microflora in IBD: Pathogens or commensals?

被引:101
作者
Sartor, RB
机构
[1] Department of Medicine, University of North Carolina, Division of Digestive Diseases, Chapel Hill, NC
[2] Department of Medicine, University of North Carolina, Division of Digestive Diseases, Chapel Hill
关键词
microflora; lumen; inflammation; Crohn's disease;
D O I
10.1002/ibd.3780030309
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Both pathogenic and normal enteric microflora can induce and perpetuate chronic intestinal inflammation with systemic manifestations in genetically susceptible hosts. At the present time, there is no convincing indication that the majority of cases of ulcerative colitis or Crohn's disease is caused by persistent infection by Mycobacterium paratuberculosis, measles, Listeria monocytogenes, or Helicobacter species, but this possibility remains a valid hypothesis. Transient infection with any of a number of pathogens including upper respiratory tract infections and common enteric pathogens could provide one of the environmental triggers that initiate or reactivate IBD, which is then perpetuated in susceptible hosts by resident (not pathogenic) commensal luminal bacteria. Recent results in animal models demonstrate the absence of colitis, gastritis, and arthritis in a sterile (germ-free) environment, showing the importance of resident bacteria as persistent antigenic stimuli in the genetically susceptible hosts. Furthermore, there is an indication that not all normal luminal bacteria have equal capacities to induce mucosal injury, since some species can induce inflammation (Bacteroides), some are neutral (E. coli) and others may be protective (Lactobacilli). These observations have important therapeutic implications, such that altering luminal bacterial components and thereby decreasing the persistent antigenic drive offer alternative or adjuvant approaches to ongoing efforts to block mucosal immune responses to these stimuli.
引用
收藏
页码:230 / 235
页数:6
相关论文
共 44 条
  • [11] INFLAMMATORY BOWEL-DISEASE AND ADENOMAS IN MICE EXPRESSING A DOMINANT-NEGATIVE N-CADHERIN
    HERMISTON, ML
    GORDON, JI
    [J]. SCIENCE, 1995, 270 (5239) : 1203 - 1207
  • [12] PRODUCTS OF ENTEROPATHOGENIC ESCHERICHIA-COLI INHIBIT LYMPHOCYTE-ACTIVATION AND LYMPHOKINE PRODUCTION
    KLAPPROTH, JM
    DONNENBERG, MS
    ABRAHAM, JM
    MOBLEY, HLT
    JAMES, SP
    [J]. INFECTION AND IMMUNITY, 1995, 63 (06) : 2248 - 2254
  • [13] KROK A, 1981, SCAND J GASTROENTERO, V16, P569
  • [14] IMMUNOCYTOCHEMICAL EVIDENCE OF LISTERIA, ESCHERICHIA-COLI, AND STREPTOCOCCUS ANTIGENS IN CROHNS-DISEASE
    LIU, Y
    VANKRUININGEN, HJ
    WEST, AB
    CARTUN, RW
    CORTOT, A
    COLOMBEL, JF
    [J]. GASTROENTEROLOGY, 1995, 108 (05) : 1396 - 1404
  • [15] Mucosal antibodies in inflammatory bowel disease are directed against intestinal bacteria
    Macpherson, A
    Khoo, UY
    Forgacs, I
    PhilpottHoward, J
    Bjarnason, I
    [J]. GUT, 1996, 38 (03) : 365 - 375
  • [16] Madsen KL, 1997, GASTROENTEROLOGY, V112, pA1030
  • [17] Impaired defense of intestinal mucosa in mice lacking intestinal trefoil factor
    Mashimo, H
    Wu, DC
    Podolsky, DK
    Fishman, MC
    [J]. SCIENCE, 1996, 274 (5285) : 262 - 265
  • [18] TISSUE INTERLEUKIN-1 AND INTERLEUKIN-1 RECEPTOR ANTAGONIST EXPRESSION IN ENTEROCOLITIS IN RESISTANT AND SUSCEPTIBLE RATS
    MCCALL, RD
    HASKILL, S
    ZIMMERMANN, EM
    LUND, PK
    THOMPSON, RC
    SARTOR, RB
    [J]. GASTROENTEROLOGY, 1994, 106 (04) : 960 - 972
  • [19] MILLAR DS, 1995, P 4 INT C PAR CAMBR, P320
  • [20] On the etiology of Crohn disease
    Mishina, D
    Katsel, P
    Brown, ST
    Gilberts, ECAM
    Greenstein, RJ
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1996, 93 (18) : 9816 - 9820